首页> 外文期刊>Autoimmunity >Autoantibodies directed against ribosomal proteins in systemic lupus erythematosus and rheumatoid arthritis: a comparative study.
【24h】

Autoantibodies directed against ribosomal proteins in systemic lupus erythematosus and rheumatoid arthritis: a comparative study.

机译:针对系统性红斑狼疮和类风湿关节炎中核糖体蛋白的自身抗体:一项比较研究。

获取原文
获取原文并翻译 | 示例
           

摘要

To assess the specificity of autoantibodies (aAbs) directed against the ribosomal P-proteins (RPPaAbs) in patients with systemic lupus erythematosus (SLE) and to investigate aAbs directed to other ribosomal proteins, 100 SLE, 100 rheumatoid arthritis (RA), 25 thyroiditis and 20 blood-donors were analyzed in a comparative study using an immunoblotting technique. Forty-eight percent of SLB sera contained aAbs directed against the ribosomal proteins of the 60 S subunit compared to 9% for RA, 5% for blood donors and 0% for thyroiditis. RPPaAbs were only found in SLE (25%) and aAbs directed to a 31 kDa and/or a 28 kDa protein of the 60 S subunit were found with a statistically higher frequency for SLE compared to RA (p < 0.0001). aAbs directed to proteins of the 40 S subunit were present in 63% of the SLE sera compared to 42% for RA, 4% for thyroiditis and 5% for blood donors. The number of positive sera was not statistically different between SLE and RA but a much more intense reactivity was observed for SLE sera. These data shows that the aAbs against the ribosomal proteins, especially the P-proteins along with the 28 and 31 kDa proteins of the 60 S subunit proteins, can be considered as useful biological markers for t he diagnosis of SLE inclinical practice.
机译:评估针对系统性红斑狼疮(SLE)患者针对核糖体P蛋白(RPPaAb)的自身抗体(aAbs)的特异性,并研究针对其他核糖体蛋白,100 SLE,100类风湿性关节炎(RA),25甲状腺炎的aAbs使用免疫印迹技术在一项比较研究中分析了20个献血者。 SLB血清中有48%包含针对60 S亚基核糖体蛋白的aAb,而RA为9%,献血者为5%,甲状腺炎为0%。仅在SLE中发现RPPaAb(25%),发现与60 S亚基的31 kDa和/或28 kDa蛋白相对应的aAbs与RA相比,其SLE的统计学上具有更高的发生频率(p <0.0001)。 63%的SLE血清中存在针对40 S亚基蛋白的aAb,而RA为42%,甲状腺炎为4%,献血者为5%。 SLE和RA之间阳性血清的数量无统计学差异,但观察到SLE血清的反应性强得多。这些数据表明,针对核糖体蛋白的抗体,尤其是P蛋白以及60 S亚基蛋白的28 kDa和31 kDa蛋白,可以被认为是诊断SLE临床实践的有用生物标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号